Evidence map›Paper›PMID 20417247›Full record

ReviewProgress in neurobiology2010

Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression.

Richard C Shelton, Andrew H Miller

Open access · greenAbstract readReview
In one paragraph

Review in Progress in neurobiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 256 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Inflammation and treatment strategies for suicidal behavior.The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Richard C SheltonVanderbilt University, 1500 21st Avenue South, Suite 2200, Nashville, TN 37212, USA. richard.shelton@vanderbilt.edu
Andrew H Miller
Vanderbilt University · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
X LINKED NYSTAGMUS SYNDROME WITH FEATURES OF ALBINISMM01RR000039 · NCRR · EMORY UNIVERSITY · PI VACCARINO, VIOLA · 1985 to 2007
$21.3M
Phenotyping Major Depression with Increased InflammationR01MH087604 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2010 to 2014
$2.2M
HIV/AIDS CLINICAL RESEARCH TRAINING PROGRAMT32MH020018 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 1998 to 2008
$1.3M
Pathophysiology of IFN-alpha-induced Sleep DisturbancesR01HL073921 · NHLBI · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2004 to 2008
$1.3M
Neuroimmune Mechanisms of Glucocorticoid ResistanceR01MH075102 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2006 to 2010
$1.0M
Signal Transduction in DepressionR01MH073630 · NIMH · VANDERBILT UNIVERSITY · PI SHELTON, RICHARD CHARLES · 2006 to 2008
$906k
DEPRESSION--PSYCHOPATHOLOGY BEYOND THE RECEPTORSR01MH052339 · NIMH · VANDERBILT UNIVERSITY · PI SHELTON, RICHARD CHARLES · 1996 to 2002
$747k
Pathology and Treatment of Cytokine-Induced DepressionK05MH069124 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2004 to 2008
$585k
MOLECULAR NEUROBIOLOGY OF DEPRESSIONK24MH001741 · NIMH · VANDERBILT UNIVERSITY · PI SHELTON, RICHARD CHARLES · 1999 to 2003
$425k
NCATS NIH HHS UL1 TR000454NCRR NIH HHS M01 RR000039NCRR NIH HHS M01RR00039NCRR NIH HHS UL1 RR025008NHLBI NIH HHS HL073921NHLBI NIH HHS R01 HL073921NIMH NIH HHS K05 MH069124NIMH NIH HHS K24 MH001741NIMH NIH HHS MH01741NIMH NIH HHS MH020018NIMH NIH HHS MH069124NIMH NIH HHS MH073630NIMH NIH HHS MH075102NIMH NIH HHS MH52339NIMH NIH HHS R01 MH052339NIMH NIH HHS R01 MH073630NIMH NIH HHS R01 MH075102NIMH NIH HHS R01 MH087604NIMH NIH HHS T32 MH020018
6 · The paper itself

Abstract

Obesity and related metabolic conditions are of epidemic proportions in most of the world, affecting both adults and children. The accumulation of lipids in the body in the form of white adipose tissue in the abdomen is now known to activate innate immune mechanisms. Lipid accumulation causes adipocytes to directly secrete the cytokines interleukin (IL) 6 and tumor necrosis factor alpha (TNFalpha), but also monocyte chemoattractant protein 1 (MCP-1), which results in the accumulation of leukocytes in fat tissue. This sets up a chronic inflammatory state which is known to mediate the association between obesity and conditions such as cardiovascular disease, type 2 diabetes, and cancer. There is also a substantial literature linking inflammation with risk for depression. This includes the observations that: (1) people with inflammatory diseases such as multiple sclerosis, cardiovascular disease, and psoriasis have elevated rates of depression; (2) many people administered inflammatory cytokines such as interferon alpha develop depression that is indistinguishable from depression in non-medically ill populations; (3) a significant proportion of depressed persons show upregulation of inflammatory factors such as IL-6, C-reactive protein, and TNFalpha; (4) inflammatory cytokines can interact with virtually every pathophysiologic domain relevant to depression, including neurotransmitter metabolism, neuroendocrine function, and synaptic plasticity. While many factors may contribute to the association between inflammatory mediators and depression, we hypothesize that increased adiposity may be one causal pathway. Mediational analysis suggests a bi-directional association between adiposity and depression, with inflammation possibly playing an intermediary role.

Indexed as

Adipose TissueAdiposityAnimalsAntidepressive AgentsAnti-Inflammatory AgentsCytokinesDepressionHumansInflammationObesityRisk FactorsAntidepressive AgentsAnti-Inflammatory AgentsCytokines

Identifiers

PMID20417247
PMCPMC2929810
OpenAlexW2082182063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.